4 material Form 8-K filings that 4 companies we cover made with the SEC in April 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Vicor reported first-quarter 2023 results for the period ended March 31, 2023, with revenue up 10.8% year over year to $97.8 million and net income of $11.2 million, or $0.25 per diluted share, versus $5.0 million, or $0.11, a year earlier. Revenue fell 7.3% from the fourth quarter of 2022, and backlog declined 36.0% year over year to $271.3 million, so the picture is mixed beyond the year-over-year profit gain.
Revenue of $97.8 million, up 10.8% from $88.3 million a year earlier but down 7.3% from $105.5 million in Q4 2022
Net income of $11.2 million, or $0.25 per diluted share, compared with $5.0 million, or $0.11, a year earlier
Gross margin of 47.6% of revenue, up from 42.6% a year earlier; backlog of $271.3 million, down 36.0% from $423.7 million a year earlier
Cash and cash equivalents of approximately $192.9 million as of March 31, 2023; the company's conference call is set for 5:00 p.m. Eastern Time on April 25, 2023
The trust amended its Controlled Equity Offering sales agreement with Cantor Fitzgerald & Co. to allow sales of common shares with an aggregate initial offering price of up to $150 million. The offering commenced on April 12, 2023, under an existing shelf registration statement, and the filing does not state how many shares have been sold so far.
Maximum aggregate initial offering price raised to $150 million under the amended sales agreement
Second Amendment dated April 12, 2023; the prior first amendment referenced a limit of $88,896,812
Offering commenced April 12, 2023 under Form N-2 registration statement (File No. 333-267848)
PIMCO Municipal Income Fund II (PML) said that, effective April 12, 2023, it is permitted to invest in and originate loans as a principal investment strategy, including to borrowers rated below investment grade or unrated. The filing adds a new principal risk factor, Loan Origination Risk, covering potential illiquidity, legal costs and litigation exposure that could be borne by shareholders.
Effective as of April 12, 2023, the fund may invest in and originate loans as a principal investment strategy, with no stated limit on amount, size or borrower type beyond applicable law.
The disclosure change will appear in the shareholder report on Form N-CSR for the 12-month period ended December 31, 2023.
A new risk factor, Loan Origination Risk, notes the fund may have to hold loans for an indeterminate period and bear origination, legal and due diligence expenses borne by common shareholders.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.